John C. Lantis II, MD.  To what extent does proactive vascular access monitoring affect the incidence of AV access thrombosis and abandonment compared.

Slides:



Advertisements
Similar presentations
Risk Stratification in Renal Care Mary Jane McKendry Vice President, Operations Fresenius Disease Management Optimal Renal Care.
Advertisements

Chronic kidney disease
Introduction to Nephrology Sandeep K. Shori, D.O. Dialysis Associates Fort Worth, TX.
Chronic Kidney Disease Manju Sood GPST3. What is CKD? Chronic renal failure is the progressive loss of nephrons resulting in permanent compromise of renal.
University of North Carolina Best Access Procedures from the Dialysis Units’ Viewpoint Lesley C. Dinwiddie MSN, RN, FNP, CNN.
Chronic Kidney Disease/Dialysis Belinda Jim, MD January 15, 2009.
Haemodialysis Fistula Intervention Dr Ralph Jackson Freeman Hospital Newcastle-upon-Tyne.
Recent Advances in Management of CRF Yousef Boobess, M.D. Head, Nephrology Division Tawam Hospital.
Update of Anemia management in chronic kidney disease What is still missing.
Hemodialysis Adequacy
Renal Replacement Therapy: What the PCP Needs to Know.
Assessing Renal Patients SHARONDEEP GILL. Overview Chronic Kidney Disease History Examination Fistula Cases Clinical Topics Summary.
MANUAL CATHETER ASSOCIATED BLOOD STREAM INFECTION (CABSI) SURVEILLANCE
Strategies for Improving Adequacy Decreasing the Risk of Premature Death Educate Your Dialysis Team Review Proper Procedure for Drawing Lab Samples - Lab.
HEMODIALYSIS ADEQUACY HEMODIALYSIS ADEQUACY Laurie Vinci RN, BSN, CNN Laurie Vinci RN, BSN, CNN September 17, 2011 September 17, 2011.
MOHAMMED ALSUNAID, MD Section Head, Nephrology Department of Medicine King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia.
When to first cannulate Vascular Access for Hemodialysis Müjdat YENİCESU, M. D. October 23, 2014.
Slides current until 2008 Diabetic neuropathy. Curriculum Module III-7C Slide 2 of 37 Slides current until 2008 Diabetic foot disease – the high-risk.
The Role of the Technologist in Pre-Op Surgical Planning for AVF/AVG
Assessment of the New AVF for Maturity
GRAFT Thrombosis: Recent trends in Management
Hemodialysis access problems F1 王奕淳 / VS 李隆志
Associate professor and consultant Vascular Surgery
Screening Guidelines and Treatment Options for Abdominal Aortic Aneurysms Allen Jeremias, MD Division of Cardiology B eth I srael D eaconess M edical C.
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.
Postoperative venous thromboembolic disease prevention in the neurosurgery population Ahmad Khaldi, M.D. 1 Michael Wall, PharmD 2 T.C. Origitano, M.D.,
SM Gatmiri, MD, Nephrologist Imam Khomeini Hospital,
Different Types of IV and Dialysis Accesses
Hemodialysis. Hemodialysis (also haemodialysis) is a method for removing waste products such as potassium and urea, as well as free water from the blood.
MARC – Network 5 5 Diamond Patient Safety Program
DEFINING THE DURATION OF ANTICOAGULATION. HOW LONG TO TREAT A DVT?
Venous Doppler Remains primary modality for assessing deep venous thrombosis of upper & lower extremities Diagnostic Criteria for DVT: Most reliable is.
Access in Pediatric CRRT
Why Vascular Access Coordinator (VAC)
Hemodialysis access: guidelines, evidence and controversies Marc R Lilien, MD, PhD Pediatric nephrologist.
Routine clotting studies - a bloody waste of resources? Joanne Bratchell Lead Nurse Pre-operative Assessment St George’s Hospital, Tooting Antonia Field-Smith.
Project #2: Hemodynamic Evaluation of Arteriovenous Fistula
Findings/Discussion AV fistula with outflow stenosis far from anastomosis Stenosis typically due to fibrotic, hyperplastic or elastic lesions. –Increased.
Teun Wilmink 1) and Sarah Powers 2), Dept of Vascular Surgery 1) and Renal Medicine 2). Heart of England NHS Foundation Trust, Birmingham.
Complications of Vascular Anastomosis
Renovascular hypertension Dr Saad Al Shohaib KAUH.
GRAFT OF DIALYSIS The three most common types of access are:
Vascular Diagnostic Testing Optimum Re Charlotte A. Lee, M.D., DBIM, FLMI.
Introduction Measuring the cardiac index using ultrasound dilution during hemodialysis (HD) can be used to detect patients with an excessive access flow.
Addenbrooke’s and the Rosie Hospitals – Innovation and Excellence in Health and Care Self Cannulation Technique Regin Lagaac Clinical Nurse Specialist.
UOG Journal Club: June 2017 Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE.
Pulmonary hypertension in patients with mitral valvular heart disease before and after surgical correction .
Diagnostic Medical Sonography Program
ultrasound in the dialysis unit Case studies
EXTERNAL ARTERIOVENOUS SHUNT (AV SHUNT)
Ten Tips for Dialysis Management
Development and Internal Validation of a Predictive Model of Angioplasty Need in the Dysfunctional Vascular Access for Hemodialysis. MANUEL BENÍTEZ SÁNCHEZ.
The Role of Interventional Treatment for The Failing Grafts
Infrared Therapy Treatment for Arterio Venous Fistula
Circ Cardiovasc Imaging
Estimation of brachial artery volume flow by duplex ultrasound imaging predicts dialysis access maturation  Sae Hee Ko, MD, Dennis F. Bandyk, MD, Kelley.
CRASH 2 Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2):
Studies reporting the incident rate for thrombosis per 1000 patient days. Studies reporting the incident rate for thrombosis per 1000 patient days. Dashed.
Section 5: Intervention and drug therapy
Arteriovenous Fistula After Biopsy of Renal Transplant: Detection and Monitoring With Color Flow and Duplex Ultrasonography  MARILYN J. MORTON, D.O.,
Hypertension evaluation
Vascular access surveillance: an ongoing controversy
Diagnostic Medical Sonography Program
Frequency of critical stenosis in primary arteriovenous fistulae before hemodialysis access: Should duplex ultrasound surveillance be the standard of.
Importance of diastolic velocities in the detection of celiac and mesenteric artery disease by duplex ultrasound  Mario J. Perko, MD, Sven Just, MD, Torben.
Do normal early color-flow duplex surveillance examination results of infrainguinal vein grafts preclude the need for late graft revision?  Marc A. Passman,
Thomas A. Simone, MD, Benjamin S. Brooke, MD, PhD, Philip P
Subclavian steal syndrome from high-output brachiocephalic arteriovenous fistula: A previously undescribed complication of dialysis access  W.G. Schenk,
Roel H. D. Vaes, MD, Jan H. Tordoir, MD, PhD, Marc R
Vascular access for hemodialysis
Presentation transcript:

John C. Lantis II, MD

 To what extent does proactive vascular access monitoring affect the incidence of AV access thrombosis and abandonment compared with clinical monitoring

 Hemodynamically significant outflow stenosis leading to thrombosis is the most common cause of prosthetic access abandonment  Early studies suggested idntification and correction of these stenosis could prevent thrombosis and prolong graft longevity  RCTs have had variable results

 The National Kidney Foundation  The Canadian Society of Nephrology  Caring for Australians with Renal Impairment  Recommend frequent, regular surveillance with physical exam an some form of serial access flow measurements

 Nine studies (1363 patients)  Surveillance vs. clinical monitoring  Surveillance followed by intervention led to a non-significant reduction in risk of thrombosis (.82)  …..and a non-significant reduction in abandonment (.80)

 Three studies (207 patients) compared the effect of vascular intervention vs. observation in patients with abnormal surveillance results Intervention led to a significant reduction in the risk of access thrombosis (0.53) …and abandonment (0.76)

 2006 Robbin  Chronic HD – mean follow up 670 days  Prosthetic only  Surveillance ▪ 65 pts ▪ US every 120 days ▪ Thrombosis 18, abandonment 27  Control ▪ 61 pts ▪ Physical exam/HD parameters TIW ▪ Thrombosis 27, abandonment 26

 2006 Polkinghorne  Chronic HD – mean follow up 558 days  Autogenous only  Surveillance ▪ 68 pts ▪ Blood flow every 30 days ▪ Thrombosis 6  Control ▪ 67 pts ▪ Physical exam/dynamic venous pressure TIW ▪ Thrombosis 4

 2005 Malik  Chronic HD – mean follow up 670 days  Prosthetic 216, Autogenous 147  Surveillance ▪ 291 pts ▪ Urea recirculation, dynamic and static venous pressure, ultrasound – weekly ▪ Abandonment 7  Control ▪ 72 pts ▪ No access monitoring ▪ Abandonment 28

 The value of surveillance strongly depends on the adequacy of clinical monitoring  Clinical monitoring by skilled personnel has a positive predictive value of 70 to 90% in prosthetic grafts, a 38% sensitivity and 90% specificity

 Monitoring – is physical exam per DOQI guidelines  Absent thrill, pulsatile graft, abnormal auscultation, persistent edema, venous collaterals on the chest wall  Surveillance – refer to tests  Serial access flow measurements  Serial measurement of static dialysis venous pressure  Prepump arterial pressure  Duplex ultrasound screening

 flow rates as measured at end of dialysis  < 600 ml/min  Or a decrease of 25%  Most useful for autogenous fistula  Reverse the arterial and venous lines measuring the rate of change in ultrasound transmission in the venous line after saline  DOQI recommends: Monthly measurement

 Primarily for grafts  (Dynamic VDP) – measured at low HD flow of 200 ml/min is a relative poor marker, too many variables  Static VDP – at no dialysis flow  Ratio to SBP  >0.4 suggestive of stenosis  >mean pressure ratio is 0.5  Should use as a trending tool, not a single measurement

Indicitive of the ease with which blood is drawn from the access at any particular setting New autogenous access, if they have a problem it is at the arterial inflow Therefore, have an excessively negative arterial dialysis pressure Useful in new dialysis fistulae

 PSV at the graft venous anastomosis  PSV > 2.0 to immediate upstream velocities is predictive  Positive predictive value of 80%

 Note although thrombosis rates are lower, actual access survival is no different in the two groups  However, lower incidence of thrombosis may translate into a reduction in access related costs and hospitalizations

 RR of access thrombosis  Surveillance 90/406  No surveillance 92/387  RR of access abandonment  Surveillance 94/614  No surveillance 88/347

 Very low quality evidence  Suggests that serial surveillance of asymptomatic AV access, accompanied by intervention if an abnormality is found, tends to decrease thrombosis and abandonment vs. no surveillance  This difference is not statistically significant

 Regular clinical monitoring (inspection, palpation, auscultation and monitoring for prolonged bleeding after needle withdrawal) to detect access dysfunction –very low quality evidence  Suggest access flow monitoring or static dialysis venous pressures for routine surveillance – very low quality evidence  Suggest performing a Duplex ultrasound study or contrast imaging in accesses that display clinical signs of dysfunction or abnormal routine surveillance – very low quality evidence